growing body of evidence suggests that blockade of the renin -angiotensin system (RAS) leads to a decrease in the morbidity and mortality of patients with congestive heart failure. 1 In addition to the systemic effects, including elevation of blood pressure (BP), sodium and water retention, and activation of the sympathetic nervous system, the activated RAS has unfavorable direct effects on the heart. 2 Most of the known functions of angiotensin II (Ang II) in the cardiovascular system are mainly mediated through the Ang II type 1 (AT1) receptor. 3 In mice or rats, the AT1 receptor has 2 subtypes (AT1a and AT1b), but the AT1a receptor is predominantly expressed and functionally important in cardiomyocytes. 4,5 According to the results of in vitro experiments, activation of the AT1 receptor stimulates diverse intracellular signaling cascades and produces reactive oxygen species, which evoke hypertrophic responses in cardiomyocytes and enhance cellular proliferation and production of extracellular matrix proteins, such as collagen, in cardiac fibroblasts. 2,6 These cellular alterations that occur within the heart would promote left ventricular (LV) remodeling and contribute to the progression of heart failure. However, the effects of the AT1 receptor have been experimentally verified only in animal models of heart failure, such as a myocardial infarction model produced by coronary artery ligation, 7-9 a pacing-induced heart failure model, 10 Dahl salt-sensitive rats, 11 a pressure-overloaded model, 12,13 a shunt-induced volume-overloaded model, 14 experimental myocarditis, 15 and doxorubicininduced cardiomyopathy. 16 A number of reports have suggested that inhibition of the AT1 receptor prevents LV remodeling after myocardial infarction, 2,7-9 but it remains unknown whether it is also beneficial for dilated cardiomyopathy (DCM).Mice deficient for the gene for muscle LIM protein (MLP) have been characterized as a good model of human DCM. 17 MLP, a member of the LIM-only proteins, 18 is involved in organization of cytoarchitecture 17 and is proposed to function as a mechanosensor. 19 Approximately 35% of MLP-deficient mice (offspring of homozygous breeders) exhibit an early phenotype with marked hypertrophy and death within 10-11 days, and remainder survive into adulthood and exhibit a number of phenotypic features of human DCM (adult phenotype). 17 In the present study, we used MLP-deficient mice as a model of DCM and examined the effects of AT1 receptor blockade on disease progression using AT1a-deficient mice.
Methods
AnimalsG1 pups generated from an MLP +/-heterozygote× AT1a -/-homozygote cross were mated to created the MLP +/-/ AT1a +/-double heterozygotes (G2). G4 offspring were genCirc J 2007; 71: 1958 -1964 (Received March 29, 2007 revised manuscript received July 20, 2007; accepted July 31, 2007 Background Angiotensin II (AT) is implicated in the development of cardiac remodeling, which leads to heart failure, and pharmacological inhibition of the AT type 1 (AT1) receptor has improved mortality and morbi...